Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISC-3405 in Polycythemia Vera (PV)
NCT06985147Phase 2Active, not recruiting
- Sponsor
- Disc Medicine
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of DISC-3405 in polycythemia vera (PV), sponsored by Disc Medicine. Started Aug 2025; status: active, not recruiting.
02
Drugs
DISC-3405
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT06985147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985147.